Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enobosarm Durability Extension in SUI
NCT03508648Phase 2Withdrawn
- Sponsor
- GTx
- Start
- May 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enobosarm in stress urinary incontinence (SUI), sponsored by GTx. Planned start May 2018; status: withdrawn.
02
Drugs
enobosarm
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT03508648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03508648.